Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nathan Ross B. Bantayan"'
Autor:
Frederick Berro Rivera, Linnaeus Louisse A. Cruz, John Vincent Magalong, Jade Monica Marie J. Ruyeras, John Paul Aparece, Nathan Ross B. Bantayan, Kyla Lara-Breitinger, Martha Gulati
Publikováno v:
American Journal of Preventive Cardiology, Vol 18, Iss , Pp 100679- (2024)
Background: Multiple cardiovascular outcomes trials (CVOTs) have shown the efficacy of GLP-1RAs in reducing major adverse cardiovascular events (MACEs) for high-risk patients. However, some CVOTs failed to demonstrate cardiovascular benefits. Objecti
Externí odkaz:
https://doaj.org/article/ddaeeef737334d64a0255d15e73a22cc
Autor:
Frederick Rivera, Arcel Villanueva Adizas, Deanna Cubarrubias, Nathan Ross B. Bantayan, Sarang Choi, Genquen Philip Carado, Marc Gregory Yu, Edgar Lerma, Krishnaswami Vijayaraghavan
Publikováno v:
Journal of the ASEAN Federation of Endocrine Societies, Vol 39, Iss 1 (2023)
Non-alcoholic fatty liver disease (NAFLD) is one of the most prevalent causes of chronic liver disease worldwide which is often seen in patients with metabolic abnormalities such as those with obesity and insulin resistance. On the other hand, sarcop
Externí odkaz:
https://doaj.org/article/502e319932c14a8581b50f2fef8dc5b7
Autor:
Frederick Berro Rivera, Sarang Choi, Genquen Philip Carado, Arcel V. Adizas, Nathan Ross B. Bantayan, Gerard Jude P. Loyola, Sung Whoy Cha, John Paul Aparece, Anlene Jane B. Rocha, Siena Placino, Marie Francesca M. Ansay, Gerard Francis E. Mangubat, Mer Lorraine P. Mahilum, Abdullah Al-Abcha, Natasha Suleman, Nishant Shah, Tisha Marie B. Suboc, Annabelle Santos Volgman
Publikováno v:
American Journal of Hospice and Palliative Medicine®. :104990912311545
Heart failure (HF) is a chronic, debilitating condition associated with significant morbidity, mortality, and socioeconomic burden. Patients with end-stage HF (ESHF) who are not a candidate for advanced therapies will continue to progress despite sta